[Lymphangioleiomyomatosis: new therapeutic approaches]

Arch Bronconeumol. 2011 Dec;47(12):579-80. doi: 10.1016/j.arbres.2011.06.008. Epub 2011 Sep 15.
[Article in Spanish]
No abstract available

MeSH terms

  • Adult
  • Aromatase Inhibitors / therapeutic use*
  • Clinical Trials, Phase II as Topic
  • Doxycycline / therapeutic use*
  • Estrogen Receptor Modulators / therapeutic use
  • Female
  • Humans
  • Letrozole
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / epidemiology
  • Lung Neoplasms / genetics
  • Lung Neoplasms / surgery
  • Lung Transplantation
  • Lymphangioleiomyomatosis / drug therapy*
  • Lymphangioleiomyomatosis / epidemiology
  • Lymphangioleiomyomatosis / genetics
  • Lymphangioleiomyomatosis / surgery
  • Matrix Metalloproteinase Inhibitors
  • Multicenter Studies as Topic
  • Nitriles / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Registries
  • Sirolimus / therapeutic use*
  • Spain / epidemiology
  • Therapies, Investigational
  • Triazoles / therapeutic use*

Substances

  • Aromatase Inhibitors
  • Estrogen Receptor Modulators
  • Matrix Metalloproteinase Inhibitors
  • Nitriles
  • Triazoles
  • Letrozole
  • Doxycycline
  • Sirolimus